Methods of treating charcot-marie-tooth disease
AssigneeCMTx Biotech Inc.
InventorJoseph Scaduto
Life of this patent
Estimating the term…
Abstract
A method of treating Charcot Marie Tooth Disease in a human in need thereof. The method comprises systemically administering to the human a non-antibacterial tetracycline compound or antibacterial tetracycline compound, in an amount that is effective to treat Charcot Marie Tooth Disease but has substantially no antibacterial activity.
Claims20
A method of treating Charcot-Marie-Tooth Disease (CMTD) in a human in need thereof, the method comprising systemically administering to the human a non-antibacterial tetracycline compound in an amount that is effective to treat CMTD.
A method of treating Charcot-Marie-Tooth Disease (CMTD) in a human in need thereof, the method comprising systemically administering to the human a pharmaceutical composition comprising 6-demethyl-6-deoxy-4-dedimethylaminotetracycline (CMT-3) and salts thereof.
A method of treating Charcot-Marie-Tooth Disease (CMTD) in a human in need thereof, the method comprising systemically administering to the human a pharmaceutical composition comprising 4-dedimethylaminodoxycycline (CMT-8) and salts thereof.
A method of treating Charcot-Marie-Tooth Disease (CMTD) in a human in need thereof, the method comprising systemically administering to the human a pharmaceutical composition comprising 9-amino-6-demethyl-6-deoxy-4-dedimethylaminotetracycline (CMT-308) and salts thereof.
A method of treating Charcot-Marie-Tooth Disease (CMTD) in a human in need thereof, the method comprising administering systemically to the human an antibacterial tetracycline compound in an amount that is effective to treat CMTD, but has substantially no antibacterial activity.
Dependencies are inferred from the claim text.